Why a Drug Company Is Selling Patents to a Native American Tribe image

Gizmodo, September 12, 2017
By Ryan F. Mandelbaum, quoting Rachel E. Sachs (Academic Fellow Alumna)


Read the Full Article

[...] There is concern that this act may be precedent setting, and other companies may also try and transfer patents to Native American tribes to get around these patent lawsuits. Rachel Sachs, a patent law professor at Washington University in St. Louis, told Reuters that “Once the industry begins engaging in a practice, even at a low level... there are actors who will take it to its logical extreme.”

And at the end of the day, there are ethical issues no matter how you look at it. “This is a tribe that’s looking for a form of economic activity,” said Fletcher. “They’re not like states or the federal government, they don’t have a tax base. If they don’t generate the money, there’s no healthcare, police department or fire department. The tribes are really searching for revenue to maintain themselves.” [...]

health law policy pharmaceuticals rachel sachs